Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 190 | 1 | 178 | −11 |
| Shares | 55.5M | 33.8K | 58.2M | +2.79M (+5.0%) |
| Value | $410.0M | $258.0K | $395.9M | −$13.9M (−3.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 100,000 | $679.0K | 0.10% |
| New York Life Investment Management LLC | 68,665 | $466.2K | 0.01% |
| Easterly Investment Partners LLC | 60,557 | $411.2K | 0.04% |
| Profund Advisors LLC | 45,685 | $310.2K | 0.02% |
| PDT Partners, LLC | 39,933 | $271.1K | 0.04% |
| Horizon Kinetics Asset Management LLC | 27,000 | $183.3K | 0.00% |
| E Fund Management Co., Ltd. | 13,060 | $89.0K | 0.01% |
| Ghost Tree Capital, LLC | 12,500 | $85.0K | 0.03% |
| Bank of Montreal | 11,061 | $81.0K | 0.00% |
| Price T Rowe Associates Inc | 10,380 | $71.0K | 0.00% |
| Amundi | 7,701 | $52.0K | 0.00% |
| Quantbot Technologies LP | 6,500 | $44.1K | 0.00% |
| Simplex Trading, LLC | 1,706 | $11.0K | 0.00% |
| Signaturefd, LLC | 422 | $2.87K | 0.00% |
| Baker Avenue Asset Management, LP | 200 | $1.36K | 0.00% |
| Nisa Investment Advisors, LLC | 163 | $1.00K | 0.00% |
| Group One Trading, L.P. | 100 | $679 | 0.00% |
| International Assets Investment Management, LLC | 94 | $638 | 0.00% |
| 25 LLC | 80 | $555 | 0.00% |
| Belpointe Asset Management LLC | 21 | $143 | 0.00% |
Sold out (31)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 33,847 | $258.0K |